Market header image

Bulletins

You are here

2016-0819 - Suspension - Pivotal Therapeutics Inc. (PVO)

August 17, 2016

Pivotal Therapeutics Inc. is in default of CSE requirements. Effective at market close, Pivotal Therapeutics, currently the subject of a Cease Trade Order, will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective market close, August 17, 2016
Symbol: PVO

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com



CSE Listing(s):

Advertisement

Publicité

Latest CSE News

Upcoming Events

Website_2.jpg

Capital Markets Comeback Tour

Wednesday, May 11, 2022 to Thursday, June 2, 2022
2022-05-25-IR-Summit-Small-Caps_Website.jpg

IR Summit Small Caps

Wednesday, May 25, 2022 -
3:00pm to 4:00pm

Advertisement

Publicité